Promedica Health Sys., Inc. v. Fed. Trade Comm'n

Citation749 F.3d 559
Decision Date24 July 2014
Docket NumberNo. 12–3583.,12–3583.
PartiesPROMEDICA HEALTH SYSTEM, INC., Petitioner, v. FEDERAL TRADE COMMISSION, Respondent.
CourtUnited States Courts of Appeals. United States Court of Appeals (6th Circuit)

OPINION TEXT STARTS HERE

ARGUED:Douglas R. Cole, Organ Cole + Stock LLP, Columbus, Ohio, for Petitioner. Michele Arington, Federal Trade Commission, Washington, D.C., for Respondent. ON BRIEF:Douglas R. Cole, Erik J. Clark, Organ Cole + Stock LLP, Columbus, Ohio, David Marx, Jr., Stephen Y. Wu, McDermott Will & Emery LLP, Chicago, Illinois, for Petitioner. Michele Arington, John F. Daly, Federal Trade Commission, Washington, D.C., for Respondent. Beth Heifetz, Tara Stuckey Morrissey, Jones Day, Washington, D.C., Mark J. Botti, Hyland Hunt, Akin Gump Strauss Hauer & Feld LLP, Washington, D.C., for Amici Curiae.

Before: KETHLEDGE, WHITE, and STRANCH, Circuit Judges.

OPINION

KETHLEDGE, Circuit Judge.

This is an antitrust case involving a proposed merger between two of the four hospital systems in Lucas County, Ohio. The parties to the merger were ProMedica, by far the county's dominant hospital provider, and St. Luke's, an independent community hospital. The two merged in August 2010, leaving ProMedica with a market share above 50% in one relevant product market (for so-called primary and secondary services) and above 80% in another (for obstetrical services). Five months later, the Federal Trade Commission challenged the merger under § 7 of the Clayton Act, 15 U.S.C. § 18. After extensive hearings, an Administrative Law Judge and later the Commission found that the merger would adversely affect competition in violation of § 7. The Commission therefore ordered ProMedica to divest St. Luke's. ProMedica now petitions for review of the Commission's order, arguing that the Commission was wrong on both the law and the facts in its analysis of the merger's competitive effects. We think the Commission was right on both counts, and deny the petition.

I.
A.

Lucas County is located in the northwestern corner of Ohio, with approximately 440,000 residents. Toledo lies near the county's center; more affluent suburbs lie to the southwest. Two-thirds of the county's patients have government-provided health insurance, such as Medicare or Medicaid. Twenty-nine percent of the county's patients have private health insurance, which pays significantly higher rates to hospitals than government-provided insurance does. (Medicare and Medicaid reimbursements generally do not cover the providers' actual cost of services.) A relatively large proportion of the county's privately insured patients reside in the county's southwestern corner.

This case concerns the market—or markets, depending on how one defines them—for “general acute-care” (GAC) inpatient services in Lucas County. GAC comprises four basic categories of services. The most basic are “primary services,” such as hernia surgeries, radiology services, and most kinds of inpatient obstetrical (OB) services. “Secondary services,” such as hip replacements and bariatric surgery, require the hospital to have more specialized resources. “Tertiary services,” such as brain surgery and treatments for severe burns, require even more specialized resources. And “quaternary services,” such as major organ transplants, require the most specialized resources of all.

Different hospitals offer different levels of these services. There are four hospital providers in Lucas County. The most dominant is ProMedica, with 46.8% of the GAC market in Lucas County in 2009. ProMedica operates three hospitals in the county, which together provide primary (including OB), secondary, and tertiary services. The county's second-largest provider is Mercy Health Partners, with 28.7% of the GAC market in 2009. Mercy likewise operates three hospitals in the county, which together provide primary (including OB), secondary, and tertiary services. The University of Toledo Medical Center (UTMC) is the county's third-largest provider, with 13% of the GAC market. UTMC operates a single teaching and research hospital, just south of downtown Toledo, and focuses on tertiary and quaternary services. It does not offer OB services. The remaining provider is St. Luke's Hospital, which before the merger was an independent, not-for-profit hospital with 11.5% of the GAC market. St. Luke's offers primary (including OB) and secondary services, and is located in southwest Lucas County.

B.

With respect to privately insured patients, hospital providers do not all receive the same rates for the same services. Far from it: each hospital negotiates its rates with private insurers (known as Managed Care Organizations, or MCOs); and the rates themselves are determined by each party's bargaining power.

The parties' bargaining power depends on a variety of factors. An MCO's bargaining power depends primarily on the number of patients it can offer a hospital provider. Hospitals need patients like stores need customers; and hence the greater the number of patients that an MCO can offer a provider, the greater the MCO's leverage in negotiating the hospital's rates. But MCOs compete with each other just as hospitals do. And to attract patients, an MCO's health-care plan must offer a comprehensive range of services—primary, secondary, tertiary, and quaternary—within a geographic range that patients are willing to travel for each of those services. (The range is greater for some services than others.) These criteria in turn create leverage for hospitals to raise rates: to the extent patients view a hospital's services as desirable or even essential—say, because of the hospital's location or its reputation for quality—the hospital's bargaining power increases.

But another important criterion for a plan's competitiveness is its cost. Thus, if a hospital demands rates above a certain level—the so-called “walk-away” point—the MCO will try to assemble a network without that provider. For example, rather than include all four hospital providers in its network, the MCO might include only three. If a provider becomes so dominant in a particular market that no MCO can walk away from it and remain competitive, however, then that provider can demand—and more to the point receive—monopoly rates ( i.e., prices significantly higher than what the MCOs would pay in a competitive market).

Here, before the merger, MCOs in Lucas County had sometimes offered networks that included all four hospital providers, but sometimes offered networks that included only three. From 2001 until 2008, for example, Lucas County's largest MCO, Medical Mutual of Ohio, successfully marketed a network of Mercy, UTMC, and St. Luke's. Since 2000, however, no MCO has offered a network that did not include either ProMedica or St. Luke's—the parties to the merger here.

C.

The likely reason MCOs have historically found it necessary to include either ProMedica or St. Luke's in their networks is that those providers are dominant in southwest Lucas County, where St. Luke's is located. In that part of the county—relatively affluent, and with a high proportion of privately insured patients—ProMedica and St. Luke's were direct competitors before the merger at issue here. Indeed, St. Luke's viewed ProMedica as its “most significant competitor,” while ProMedica viewed St. Luke's as a [s]trong competitor”—strong enough, in fact, that ProMedica offered to discount its rates by 2.5% for MCOs who excluded St. Luke's from their networks. But in this competition ProMedica had the upper hand. It is harder for an MCO to exclude the county's most dominant hospital system than it is for the MCO to exclude a single hospital that services just one corner of the county—a corner, moreover, that the dominant system also services. And that means the MCOs' walk-away point for the dominant system is higher—perhaps much higher—than it is for the single hospital. Here, the record bears out that conclusion: ProMedica's rates before the merger were among the highest in the State, while St. Luke's rates did not even cover its cost of patient care. That was true even though St. Luke's quality ratings on the whole were better than ProMedica's.

As a result, St. Luke's struggled in the years before the merger, losing more than $25 million between 2007 and 2009. To improve matters, St. Luke's hired Daniel Wakeman, a hospital-turnaround specialist, as its CEO. Wakeman implemented a three-year plan to reduce costs, increase revenues, and regain patient volume from ProMedica. Eventually St. Luke's fortunes began to improve: by August 2010, St. Luke's was out of the red (albeit barely), and Wakeman reported that “this positive margin confirms that we can run in the black if activity stays high.”

By then, however, St. Luke's was contemplating other options. In August 2009, Wakeman presented three options to St. Luke's Board. The first was for St. Luke's to [r]emain independent” by “cut[ting] major services” until an “accepted margin is realized.” The second was for St. Luke's to [p]ush the [MCOs] ... to raise St. Luke's reimbursement rates to an acceptable margin.” Under this option, Wakeman noted, “the message [to MCOs] would be [to] pay us now (a little bit more) or pay us later (at the other hospital system contractual rates).” The third option was for St. Luke's to join one of the three other providers in Lucas County—ProMedica, Mercy, or UTMC.

Of all these options, Wakeman believed that a merger with ProMedica “ha[d] the greatest potential for higher hospital rates. A ProMedica-[St. Luke's] partnership would have a lot of negotiating clout.” Wakeman also recognized, however, that an affiliation with ProMedica could [h]arm the community by forcing higher hospital rates on them.”

Three months later, Wakeman recommended to St. Luke's Board that it pursue a merger with ProMedica. The Board accepted the recommendation the same day. Six months later, on May 25, 2010, ProMedica and St. Luke's...

To continue reading

Request your trial
29 cases
  • Steves & Sons, Inc. v. Jeld-Wen, Inc.
    • United States
    • U.S. Court of Appeals — Fourth Circuit
    • February 18, 2021
    ...the weakened-competitor defense has been described as "the Hail-Mary pass of presumptively doomed mergers," ProMedica Health Sys., Inc. v. FTC , 749 F.3d 559, 572 (6th Cir. 2014) ; cf. FTC v. Arch Coal, Inc. , 329 F. Supp. 2d 109, 153–57 (D.D.C. 2004) (one of the rare cases in which the wea......
  • United States v. Energy Solutions, Inc., Civ. No. 16–1056–SLR
    • United States
    • U.S. District Court — District of Delaware
    • July 13, 2017
    ...polyethylene, Saran, plain cellophane, and moisture proof cellophane were in separate markets); ProMedica Health Sys., Inc. v. Fed. Trade Comm'n , 749 F.3d 559, 565 (6th Cir. 2014) (recognizing that the court cannot create a separate market for each individual medical procedure even though ......
  • McWane, Inc. v. Fed. Trade Comm'n
    • United States
    • U.S. Court of Appeals — Eleventh Circuit
    • April 15, 2015
    ...FTC, 986 F.2d 1295, 1297–98 (9th Cir.1993) (reviewing FTC's market definition for substantial evidence), and ProMedica Health Sys., Inc. v. FTC, 749 F.3d 559, 566 (6th Cir.2014) (same), petition for cert. filed, No. 14–762 (Dec. 30, 2014), with, e.g., JBL Enters., Inc. v. Jhirmack Enters., ......
  • United States v. Anthem, Inc.
    • United States
    • U.S. District Court — District of Columbia
    • February 8, 2017
    ...or implicit understanding in order to restrict output and achieve profits above competitive levels." ProMedica Health Sys., Inc. v. FTC , 749 F.3d 559, 568 (6th Cir. 2014), quoting H & R Block , 833 F.Supp.2d at 77. An example of this would be parallel pricing by two gas stations located ac......
  • Request a trial to view additional results
3 firm's commentaries
  • US Federal Judge: Efficiencies Analysis Inadmissible in Antitrust Merger Trial
    • United States
    • JD Supra United States
    • September 22, 2022
    ...DOJ & FTC, Horizontal Merger Guidelines § 10 (2010) [hereinafter Horizontal Merger Guidelines]. 11 See ProMedica Health Sys., Inc. v. FTC, 749 F.3d 559, 571 (6th Cir. 2014); St. Alphonsus, 778 F.3d at 788–92; FTC v. H.J. Heinz Co., 246 F.3d 708, 720 (D.C. Cir. 2001); FTC v. Univ. Health, In......
  • COVID-19: Key US Antitrust Issues In Bankruptcy And Distressed Sales
    • United States
    • Mondaq United States
    • July 2, 2020
    ...the Court called the defense the "the Hail-Mary pass of presumptively doomed mergers." Promedica Health Sys., Inc. v. Fed. Trade Comm'n, 749 F.3d 559, 572 (6th Cir. As such, parties anticipating that they will advance arguments about the target being in distress still should be prepared to ......
  • FTC And DOJ To Host Second Public Workshop On Health Care Competition
    • United States
    • Mondaq United States
    • January 27, 2015
    ...is available here: http://www.mintz.com/newsletter/2014/Advisories/3823-0314-NAT-AFR/index.html. ProMedica Health System, Inc. v. FTC, 749 F.3d 559 (6th Cir. 2014), (upholding an FTC decision condemning a hospital acquisition and ordering a full divestiture of the acquired assets), petition......
26 books & journal articles
  • Introduction
    • United States
    • ABA Antitrust Library Intellectual Property and Antitrust Handbook. Second Edition
    • December 6, 2015
    ...§ 45(c). 235. See supra part A.3.c. 236. See California v. American Stores, 495 U.S. 271, 280-82 (1990); ProMedica Health Sys. v. FTC, 749 F.3d 559, 573 (6th Cir. 2014). 237. 28 C.F.R. § 50.6. 238. 16 C.F.R. §§ 1.5-1.6. 239. 16 C.F.R. §§ 1.1-1.4. 38 Intellectual Property and Antitrust Handb......
  • Table of Cases
    • United States
    • ABA Antitrust Library Pharmaceutical Industry Antitrust Handbook. Second Edition
    • December 8, 2018
    ...Dist. LEXIS 12053 (D. Mass. 2012), 328 Prograf Antitrust Litig., In re , 2012 WL 293850 (D. Mass. 2012), 329 ProMedica Health Sys. v. FTC, 749 F.3d 559 (6th Cir. 2014), 160 Propranolol Antitrust Litig., In re , 2017 U.S. Dist. LEXIS 53390 (S.D.N.Y. 2017), 129 Pub. Citizen Health Research Gr......
  • U.S. Enforcement Policy and Procedure
    • United States
    • ABA Antitrust Library Mergers and Acquisitions. Understanding the Antitrust Issues. Fourth Edition
    • December 6, 2015
    ...the HHI as the most prominent and accurate method of measuring market concentration.”). 111 . See, e.g. , ProMedica Health Sys. v. FTC, 749 F.3d 559, 565 (6th Cir. 2014) (citing Merger Guidelines as “useful but not binding”) , cert. denied , 2015 U.S. LEXIS 3006 (U.S. May 4, 2015); In re So......
  • State antitrust enforcement in health care markets
    • United States
    • ABA Antitrust Library State Antitrust Enforcement Handbook. Third Edition
    • December 9, 2018
    ...2011 WL 1219281 (N.D. Ohio Mar. 29, 2011). 68. ProMedica Health Sys., Inc., No. 9346, 2012 WL 2450574 (F.T.C. June 25, 2012), aff’d , 749 F.3d 559 (6th Cir. 2014), cert. denied , 135 S. Ct. 2049 (2015). 69. No. 1:12-CV-00560-BLW, 2014 WL 407446 (D. Idaho Jan. 24, 2014), aff’d , 778 F.3d 775......
  • Request a trial to view additional results

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT